Lucira’s at-home COVID-19 LAMP test breaks barrier, not dam

The first FDA-authorized at-home COVID-19 test makes it possible for symptomatic patients to get a rapid diagnosis while isolating at home, but is unlikely to open the floodgates to routine self-screening.

On Tuesday, the rapid, single-use, loop-mediated isothermal amplification (LAMP) test from Lucira Health Inc. received emergency use authorization (EUA) from FDA for use at home and in point-of-care settings. Samples must be collected by a healthcare provider when the test is used at the point-of-care on individuals under the age of 14...